NLM Digital Collections

Search

Start Over Formats Text ✖Remove constraint Formats: Text Subjects United States. Food and Drug Administration. ✖Remove constraint Subjects: United States. Food and Drug Administration. Copyright Copyright may apply ✖Remove constraint Copyright: Copyright may apply

1. CT contrast media power injectors can rupture conventional IV sets

Publication:
[Harrisburg, Pa.] : Pennsylvania Patient Safety Authority, c2008
Subject(s):
Contrast Media
Cross Infection -- prevention & control
Equipment Failure
Injections, Intravenous -- instrumentation
Tomography, X-Ray Computed -- instrumentation
Equipment Safety
Guidelines as Topic
Pressure
Humans
Pennsylvania
United States
United States. Food and Drug Administration.

2. Connecting kids to health coverage: evaluating the Child Health and Disability Prevention Gateway program

Publication:
Oakland, Calif. : California HealthCare Foundation, c2007
Subject(s):
Child Health Services -- economics
Insurance Coverage
Insurance, Health
State Health Plans -- economics
Child
Disabled Children
Eligibility Determination
Infant
Infant, Newborn
Managed Care Programs -- economics
Medically Uninsured -- statistics & numerical data
Program Development
State Government
Humans
California
United States
United States. Food and Drug Administration.

3. The effect of Medicare Part D on evergreening, generic entry, and drug prices

Author(s):
Sanzenbacher, Geoffrey T., author
Wettstein, Gal, author
Publication:
Chestnut Hill, MA : Center for Retirement Research at Boston College, May 2019
Subject(s):
Drug Costs
Drugs, Generic -- economics
Medicare Part D -- economics
Patents as Topic
Aged
Drug Industry -- economics
Economics, Pharmaceutical
Humans
United States
United States. Food and Drug Administration.
Medical Expenditure Panel Survey (U.S.)

5. Evaluation of the Medi-Cal Plan/Practice Improvement Project: executive summary

Publication:
Oakland, Calif. : California HealthCare Foundation, c2008
Subject(s):
Health Plan Implementation
Managed Care Programs -- organization & administration
Organizational Innovation
Program Evaluation
State Health Plans -- organization & administration
Chronic Disease
Disease Management
Models, Theoretical
Quality Assurance, Health Care
Humans
California
United States
United States. Food and Drug Administration.

6. Exploring the role of cost-benefit analysis in government regulations

Publication:
Washington, D.C. : AARP Public Policy Institute, c2007
Subject(s):
Health Policy -- economics
Cost-Benefit Analysis -- methods
Government Regulation
Federal Government
Decision Making
Delivery of Health Care
Government Agencies
Public Health
Quality-Adjusted Life Years
Safety
Value of Life
Humans
United States
United States. Environmental Protection Agency.
United States. Food and Drug Administration.

10. Financing county Medi-Cal eligibility and enrollment in California

Publication:
Oakland, Calif. : California HealthCare Foundation, c2012
Subject(s):
Eligibility Determination -- economics
Financing, Government -- organization & administration
Insurance Coverage -- economics
Insurance, Health -- economics
Medicaid -- economics
Budgets -- organization & administration
Eligibility Determination -- legislation & jurisprudence
Insurance Coverage -- legislation & jurisprudence
Insurance, Health -- legislation & jurisprudence
Medicaid -- legislation & jurisprudence
Medicaid -- organization & administration
Public Assistance -- economics
Humans
California
United States
United States. Food and Drug Administration.

11. Implantable devices: regulatory framework and reform options

Author(s):
Lind, Keith D., author
Publication:
Washington, DC : AARP Public Policy Institute, August 2017
Subject(s):
Government Regulation
Prostheses and Implants -- adverse effects
Prostheses and Implants -- standards
Clinical Trials as Topic
Device Approval
Equipment Failure
Equipment Safety
Product Surveillance, Postmarketing
Registries
Humans
United States
United States. Food and Drug Administration.

12. Keeping America's food safe: a blueprint for fixing the food safety system at the U.S. Department of Health and Human Services

Author(s):
Levi, Jeffrey, author
Segal, Laura M., author
Vinter, Serena, author
Publication:
Washington, DC : Trust for America's Health, March 2009
Subject(s):
Consumer Product Safety
Food Industry -- organization & administration
Organizational Policy
Health Care Reform
Leadership
Legislation, Food
Humans
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.

13. Measuring up?: end-of-life cancer care in California

Author(s):
Brownlee, Shannon, author
Publication:
Oakland, CA : California HealthCare Foundation, [2013]
Subject(s):
Hospice Care -- statistics & numerical data
Hospital Mortality
Neoplasms -- mortality
Palliative Care -- statistics & numerical data
Terminal Care -- statistics & numerical data
Antineoplastic Agents -- therapeutic use
Forecasting
Hospice Care -- trends
Intensive Care Units -- statistics & numerical data
Intensive Care Units -- trends
Medicare
Neoplasms -- drug therapy
Palliative Care -- trends
Terminal Care -- trends
Time Factors
Humans
California
United States
United States. Food and Drug Administration.

15. Physician assistants and nurse practitioners in specialty care: six practices make it work

Publication:
Oakland, Calif. : California HealthCare Foundation, c2009
Subject(s):
Dermatology
Gastroenterology
Nurse Practitioners
Orthopedics
Physician Assistants
Practice Management, Medical
Ambulatory Care
Health Services Accessibility
Health Services Needs and Demand
Health Workforce
Models, Economic
Nurse Practitioners -- education
Nurse Practitioners -- statistics & numerical data
Nurse's Role
Physician Assistants -- education
Physician Assistants -- statistics & numerical data
Quality of Health Care
Role
Waiting Lists
Humans
California
United States. Food and Drug Administration.

17. A sense of déjà vu: the debate surrounding state biosimilar substitution laws

Author(s):
Purvis, Leigh, author
Publication:
Washington, D.C. : AARP Public Policy Institute, September 2014
Subject(s):
Biological Products -- economics
Biological Products -- therapeutic use
Biosimilar Pharmaceuticals -- economics
Biosimilar Pharmaceuticals -- therapeutic use
Drug Costs
Drug Substitution
Legislation, Drug
Drugs, Generic -- economics
Federal Government
State Government
Humans
United States
United States. Food and Drug Administration.
United States.

18. Snapshots of recent state initiatives in Medicaid prescription drug cost control

Author(s):
Young, Katherine, author
Garfield, Rachel, author
Publication:
Menlo Park, CA : Henry J. Kaiser Family Foundation, February 2018
Subject(s):
Cost Control -- statistics & numerical data
Cost Control -- trends
Drug Costs -- statistics & numerical data
Drug Costs -- trends
Health Expenditures -- statistics & numerical data
Health Expenditures -- trends
Medicaid -- economics
Medicaid -- trends
Disclosure
Drugs, Generic -- economics
Economics, Pharmaceutical
Federal Government
Forecasting
Formularies as Topic
State Government
Humans
United States
United States. Food and Drug Administration.